Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2007

View Archived Issues

New therapeutic agents for cancer covered in recent patents

Novel vaccine may be useful to treat familial ALS

Merck Frosst and Nippon Soda patents disclose new agents for treating eye disorders

Recent patents claim novel therapeutic agents for inflammatory disorders

Lithium starts clinical evaluation for the treatment of spinal cord injury

AT-101 monotherapy induces responses in hormone-refractory prostate cancer

Addition of oblimersen to docetaxel may not be beneficial in advanced prostate cancer

Epix reviews 2006 accomplishments

Alpharadin improves survival in hormone-refractory prostate cancer

CCR5: a novel target for asthma therapy

Advancis discusses Amoxicillin PULSYS refusal to file letter with FDA

Migraine prophylaxis compound BF-1 completes first clinical trial

Fenretinide receives orphan drug designations in U.S. and E.U.

Xoma collaborations take new directions

Futura Medical announces DermaSys as brand name for gel technology

Evotec and Interprotein collaborate on IL-6 inhibitor program

TG-100801 completes first phase I study for macular degeneration

PPD acquires exclusive license to novel Ranbaxy statin

Davanat filed for E.U. orphan drug status, advancing in phase II trials

Jerini plans Q3 NDA submission for icatibant in HAE

Second part of phase I study investigates R-7128 in HCV genotype 1 patients

Enrollment completed in phase II trials of Uvidem in melanoma

Accentia acquires rights to Revimmune

Positive interim results for Albuferon in treatment-naive chronic HCV genotype 1

Preliminary progression-free survival data from phase III study of MyVax

Neumune increases survival in primates with acute radiation syndrome

Levemir approved in E.U. in combination with oral antidiabetic drugs

Prevenar recommended for E.U. approval for pneumonia and acute otitis media

Vaprisol approved for treatment of hypervolemic hyponatremia

Tykerb studied in phase III trial for head and neck cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...